Just 28 percent of air cargo companies say they feel prepared to transport COVID-19 vaccines, according to a survey conducted by the International Air Cargo Association and Pharma.Aero, an organization of air cargo carriers that specialize in transporting pharmaceuticals.
The survey, which includes 181 companies from different countries, found that 12 percent feel “very unprepared” to transport a COVID-19 vaccine when one is authorized, and 45 percent of companies that are able to handle subzero temperatures say they have such capabilities across all of their locations.
The air cargo companies’ biggest concern now is the ability to ensure vaccine temperatures are maintained during air transportation, according to the survey. Two vaccines in late-stage testing — one from Moderna and one from Pfizer — use a gene-based technology that requires the shots to be stored at subzero temperatures.
Ten percent of the surveyed companies said they’re unable to handle temperature-controlled shipments at all.
The companies said they need information as early as possible on trade-lanes, product specifications and specific handling, storage and security conditions to properly plan for vaccine transportation.
Find the full survey here.
More articles on supply chain:
171 COVID-19 testing sites ordered shut for failing to meet US standards
Amazon forms partnership to improve temperature-sensitive vaccine distribution
Labs squeezed for staff to meet COVID-19 testing demand
© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.